date,title,source
Oct-18-18,"Report: Exploring Fundamental Drivers Behind Syndax Pharmaceuticals, Arconic, Del Taco Restaurants, Aerohive Networks, KalVista Pharmaceuticals, and Adtalem Global Education  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-25-18,Syndax to Host Conference Call to Provide Update on the Phase 3 Breast Cancer Trial (E2112) and to Announce its Registration Trial of Entinostat with Keytruda in PD-(L)1 Refractory Non-Small Cell Lung Cancer,PR Newswire
Oct-26-18,"The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default",Benzinga
Oct-29-18,"Syndax to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 5, 2018",PR Newswire
Nov-01-18,Syndax Pharmaceuticals Announces Presentations at the 60th American Society of Hematology Annual Meeting,PR Newswire
Nov-05-18,"Syndax Pharmaceuticals (SNDX) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-05-18,Syndax Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Clinical and Business Update,PR Newswire
Nov-12-18,"Investor Expectations to Drive Momentum within CommScope Holding, AMC Networks, Henry Schein, Lindblad Expeditions, Apple Hospitality REIT, and Syndax Pharmaceuticals  Discovering Underlying Factors of Influence",GlobeNewswire
Dec-03-18,Syndax Pharmaceuticals Announces Presentation of Preclinical Data from Menin-MLL Program at the 60th American Society of Hematology Annual Meeting,PR Newswire
Dec-04-18,Edited Transcript of SNDX earnings conference call or presentation 5-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Jan-04-19,"Can We See Significant Institutional Ownership On The Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Share Register?",Simply Wall St.
Jan-07-19,Syndax Highlights 2019 Clinical and Corporate Outlook,PR Newswire
Feb-12-19,"New Research: Key Drivers of Growth for Cronos Group, Spectrum Brands, Black Hills, Entercom Communications, CSS Industries, and Syndax Pharmaceuticals  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Feb-25-19,Syndax Pharmaceuticals (SNDX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release,Zacks
Feb-27-19,Syndax Announces Clinical Data from its Entinostat Immuno-oncology Program Selected for Two Oral Presentations at the American Association for Cancer Research Annual Meeting 2019,PR Newswire
Feb-28-19,"Syndax to Announce Fourth Quarter and Year-end 2018 Financial Results and Host Conference Call and Webcast on March 7, 2019",PR Newswire
Mar-06-19,Syndax to Present at the Cowen 39th Annual Health Care Conference,PR Newswire
